
Sign up to save your podcasts
Or


What does the LiGHT trial tell us about glaucoma care beyond pressure control?
Alice and Daniel explore the original randomized trial, the six-year outcomes, SLT after prior drops, and the latest findings on ocular surface and oculoplastic morbidity. This 4-minute 44-second episode highlights the evidence, limitations, and takeaways for clinicians and researchers.
We discuss dry eye in the broader context of ocular surface disease; the study's ocular surface percentages are not dry-eye-specific rates. We also explain why later exploratory analyses should not be interpreted as newly randomized comparisons or proof of individual-drug effects.
Research Pods | SRA Journal Watch | Sengupta’s Research Academy
Narrated by AI voices Alice and Daniel.
Educational discussion, not individualized medical advice. The Nicol 2026 discussion is based on its published abstract; it is a post hoc secondary analysis.
STUDIES / DOI LINKS
1. Gazzard et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet, 2019.
https://doi.org/10.1016/S0140-6736(18)32213-X
2. Gazzard et al. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension. Ophthalmology, 2023.
https://doi.org/10.1016/j.ophtha.2022.09.009
3. Konstantakopoulou et al. Selective Laser Trabeculoplasty After Medical Treatment for Glaucoma or Ocular Hypertension. JAMA Ophthalmology, 2025.
https://doi.org/10.1001/jamaophthalmol.2024.6492
4. Nicol et al. Oculoplastic and ocular surface morbidity after medication-first therapy versus selective laser trabeculoplasty: A 6-year analysis of the LiGHT trial. European Journal of Ophthalmology, online 12 November 2026.
https://doi.org/10.1177/11206721261505024
A recent poster presented at the American Heart Association, March 2024, using data from the NHANES dataset, showed that Intermittent Fasting (Time restricted Eating) for more than 16 hours a day led to a 91% increased risk of death over the next 8-10 years.
Planning a study requires attention to detail. I have broken these down into 10 steps which I call the 10 commandments. These are:
You can also read about this on the SRA blog.
In this episode of Research Live, we meet professor Amod Gupta (Padmashree). Professor Gupta has been the dean of PGI, Chandigarh in the past, has published 380 papers in peer-reviewed journals, and has more than 40 prestigious awards to his credit. Here he tells us how he initiated his research journey, what motivated him, his mentor, his first publication, how he approached biostatistics, constructed those immaculate manuscripts, and how he achieved a work-life balance. His parting message to researchers is a good one, so make sure you watch till the end.
From the publisher's feed